| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2004 | US20040033505 Novel peptide, an n-acetylgalactosamine transferase-28 and the polynucleotide encoding polypeptide |
| 02/19/2004 | US20040033497 Comprises nucleotide sequences coding membrane protein associated with lymphocyte development and tolerances for diagnosis and treatment of autoimmune diseases |
| 02/19/2004 | US20040033493 Comprises membrane and/or enzymatic polypeptide for use in prevention, diagnosis and treatment of cancer, diabetes, cardiomyopathy and atherosclerosis; gene therapy |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033256 Long-acting insulin formulation that may be aerosolized for pulmonary administration. |
| 02/19/2004 | US20040033244 Such as acute lymphocytic leukemia, chronic lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphoma |
| 02/19/2004 | US20040033243 Containing stabilizer, solubilizer, chelator, bulking agent, tonicity adjuster and buffer; fewer degradants; consistent potency |
| 02/19/2004 | US20040033241 The botulinum toxin is released from the carrier upon implantation in a human patient. |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | US20040033231 First domain comprising a PP14 polypeptide sequence and a second domain comprising a polypeptide sequence of the Fc region of an immunoglobulin protein; treatment of immune system diseases and disorders |
| 02/19/2004 | US20040033230 Breast tumor polypeptides, polynucleotides that encode them, antigen presenting cells that express them, and T cells that are specific for cells that express them. |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033221 Method for the treatment of chemonucleolysis |
| 02/19/2004 | US20040033220 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 02/19/2004 | US20040033218 Extracellular matrix (ecm); cell and genetic therapy |
| 02/19/2004 | US20040033217 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 02/19/2004 | US20040033211 Antigen arrays for treatment of bone disease |
| 02/19/2004 | US20040033210 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor |
| 02/19/2004 | US20040033209 Administering a chimeric polypeptide that has a domain that binds to a chemokine receptor and a second domain that binds to a t cell surface polypeptide, a dendritic cell surface polypeptide or a cell toxin; antiasthmatics |
| 02/19/2004 | US20040033200 Modified FVII in treatment of ARDS |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2496002A1 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | CA2495563A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | CA2495498A1 Use of cgrp antagonist compounds for treatment of psoriasis |
| 02/19/2004 | CA2495289A1 Interferon-.alpha. induced gene |
| 02/19/2004 | CA2495222A1 Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/19/2004 | CA2495112A1 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494551A1 Improved method to identify targeting molecules |
| 02/19/2004 | CA2494156A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/19/2004 | CA2494108A1 Amyloid immunization and cox-2 inhibitors for the treatment of alzheimer's disease |
| 02/19/2004 | CA2493487A1 Method for isolating an intestinal cholesterol binding protein |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2491052A1 Thrombin peptide derivatives |
| 02/18/2004 | EP1389637A1 Novel forms of interfering RNA molecules |
| 02/18/2004 | EP1389624A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/18/2004 | EP1389306A2 Method for detecting progredient chronic dementia, and corresponding peptides and detection reagents |
| 02/18/2004 | EP1389237A2 Novel fibroblast growth factors |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389234A2 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 02/18/2004 | EP1389219A2 Dimerized t-cell receptor fragment, its compositions and use |
| 02/18/2004 | EP1389217A2 Antimicrobial polypeptide |
| 02/18/2004 | EP1389200A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 02/18/2004 | EP1389186A2 Recombinant simian gpr3 receptor |
| 02/18/2004 | EP1389137A2 Compositions for protein delivery via the pulmonary route |
| 02/18/2004 | EP1389130A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 02/18/2004 | EP1389129A1 Methods of treating respiratory conditions |
| 02/18/2004 | EP1389128A2 Method for inhibiting atherosclerotic plaque formation |
| 02/18/2004 | EP1389126A1 Retrocyclins: antiviral and antimicrobial peptides |
| 02/18/2004 | EP1389125A1 Cross-linked gelatin composition comprising a wetting agent |
| 02/18/2004 | EP1389123A1 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 02/18/2004 | EP1389111A1 COMPOSITION FOR INHIBITING HIV ACTIVITY EXTRACTED FROM i PAECILOMYCES SP. /i (TOCHU-KASO) J300 |
| 02/18/2004 | EP1389108A2 Methods for selective immunomodulation using pimecrolimus |
| 02/18/2004 | EP1389086A1 Topical compositions containing nonimmunosuppressive cyclosporin-derivatives for treating hair loss |
| 02/18/2004 | EP1389044A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 02/18/2004 | EP1389043A1 Foot and mouth disease virus vaccine |
| 02/18/2004 | EP1389042A1 Sprr1a and axonal regeneration |
| 02/18/2004 | EP1237408B1 Pour-on formulations |
| 02/18/2004 | EP1143988B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases |
| 02/18/2004 | EP1131089B1 Stable aqueous insulin preparations without phenol and cresol |
| 02/18/2004 | EP1123314B1 Use of a cytokine-producing lactococcus strain to treat colitis |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP1076663B1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/18/2004 | EP1028744B1 Neuronal uses of bmp-11 |
| 02/18/2004 | EP1000086B1 Alatrofloxacin parenteral compositions |
| 02/18/2004 | EP0994696B1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 02/18/2004 | EP0948337B1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | EP0941110B1 Uses of keratinocyte growth factor-2 |
| 02/18/2004 | EP0865294B1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 02/18/2004 | EP0863765B1 Pharmaceutical compositions of cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0728012B1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/18/2004 | EP0720482B1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/18/2004 | EP0691852B1 Valproic acid covalently bonded to a lysophospholipid |
| 02/18/2004 | CN1476480A Isolated peptides which bind to HLA-C molecules and uses thereof |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/18/2004 | CN1476334A Use of bromelain for treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 02/18/2004 | CN1476333A Composition for diminishing neutral fat blood |
| 02/18/2004 | CN1476330A Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 02/18/2004 | CN1476328A Treatment of osteoporosis |
| 02/18/2004 | CN1476322A Use of cyclosporin A7-thioamide derivatives for hair growth |
| 02/18/2004 | CN1476321A Use of cyclosporin A7-thioamide derivatives for hair growth |
| 02/18/2004 | CN1475577A Recombination human bone shaping protein-7 mature peptide |
| 02/18/2004 | CN1475570A Cutin forming cell growth factor-2 |
| 02/18/2004 | CN1475568A New type human death resist protein, its coded sequence and use |
| 02/18/2004 | CN1475505A Human composite type alpha interferon protein N terminal tag structure |
| 02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
| 02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |
| 02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
| 02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
| 02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
| 02/18/2004 | CN1475276A Mixed preparation for enhancing physical cancer cell chemical theray sensitirity |
| 02/18/2004 | CN1475275A Mannan peptide freeze dried powder ampoule for injection |
| 02/18/2004 | CN1475274A Cardiotonic drug using tripeptide or its derivatire as effective component |